Autoimmunity
Upcoming SlideShare
Loading in...5
×
 

Like this? Share it with your network

Share

Autoimmunity

on

  • 3,417 views

 

Statistics

Views

Total Views
3,417
Views on SlideShare
3,417
Embed Views
0

Actions

Likes
3
Downloads
53
Comments
3

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Autoimmunity Document Transcript

  • 1. Autoimmunity Autoimmunity • Immune recognition and injury of self tissues (autoimmunity) results from a loss of self tolerance. K.J.Goodrum 2006 Self Tolerance Peripheral T cell Tolerance Mechanisms • Tolerance to self is acquired by clonal • Immunological Ignorance: Very few self deletion or inactivation of developing proteins contain peptides that are presented lymphocytes. by a given MHC molecule at a level – Clonal deletion by ubiquitous self antigens sufficient for T cell activation,. Autoreactive T cells are present but not – Clonal inactivation by tissue-specific normally activated. antigens presented in the absence of co- stimulatory signals • Suppressor or regulatory T cells: mediate active suppression of autoreactive cells 1
  • 2. Peripheral T cell Tolerance Peripheral B cell Tolerance Mechanisms Mechanisms • Contact with soluble antigens: • Immunologically privileged sites: no lymphatic drainage or non-vascularized – downregulation of surface IgM, areas; presence of immunosuppressive inhibition of signaling anergic factors & FasL cells – Fas-mediated apoptosis of anergic B cell following secondary encounter with CD4 T cell Peripheral B cell Tolerance Mechanisms Peripheral B cell Tolerance Mechanisms • Contact with soluble antigens • Lack of T helper cell signals: – Apoptosis of autoreactive B cells – anergy generated by somatic hypermutation in – inhibited migration into follicles & germinal centers apoptosis in T cell areas of lymph tissue 2
  • 3. Loss of Self Tolerance • Most self peptides are presented at levels too low to engage effector T cells whereas those presented at high levels induce clonal deletion or anergy. • Autoimmunity arises most frequently to Tissue-specific antigens with only certain MHC molecules that present the peptide at an intermediate level recognized by T cells without inducing tolerance. MHC Association with Autoimmune Disease Fig. 13.33 • The level of autoantigenic peptide presented is determined by polymorphic residues in MHC molecules that govern the affinity of peptide binding. • Autoimmune diseases are associated with particular MHC genotypes. 3
  • 4. MHC Association with Autoimmune Disease • Only a few peptides can act as Fig. 13.4 autoantigens so there are a relatively few autoimmune syndromes. Type I Diabetes association with • Individuals with a particular HLA genotype autoimmune disease tend to recognize the same antigens with the same MHC. Mechanisms for Activation of Mechanisms for Activation of Autoreactive Lymphocytes Autoreactive Lymphocytes • Infectious triggers: • Infectious triggers: – stimulation of co-stimulatory signals, – Superantigen activity/polyclonal inappropriate MHC II expression, or cytokines activation – Molecular mimicry (cross-reaction) – Release of sequestered antigens – T cell bypass (pathogen binding to self protein/provision of carrier T cell epitope) 4
  • 5. Infectious Mechanisms that Break Self-Tolerance Fig. 13.42 Fig. 13.1 Organ-specific Autoimmune diseases • Antigens and autoimmunity restricted to specific organs in the body – Type I diabetes – Goodpasture’s syndrome – Multiple sclerosis – Grave’s disease – Hashimoto’ thyroiditis – Myasthenia gravis 5
  • 6. Systemic Autoimmune Disease • Antigens and autoimmunity are distributed in many tissues (systemic) – Rheumatoid arthritis – Systemic lupus erythematosus – Scleroderma – Primary Sjogrens’s syndrome – polymyositis 6
  • 7. Determinant spreading 7